Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery

Abstract Tyrosine kinase inhibitors (TKIs) remain a major focus of targeted therapeutic discovery, yet current discovery pipelines are constrained by resistance development, limited scaffold diversity, and high attrition rates. Entomopathogenic fungi (EPF) represent an underexplored microbial resource with significant biosynthetic potential for generating kinase-relevant secondary metabolites. Recent genomic studies reveal that EPF encode diverse and largely cryptic biosynthetic gene clusters (BGCs), including polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS), and hybrid pathways capable of producing structurally complex bioactive compounds. This mini-review examines the biotechnological exploitation of EPF for TKI discovery, focusing on fungal metabolites with direct or indirect kinase-related activity, genome mining strategies, biosynthetic logic, pathway regulation, and engineering approaches for metabolite production. Although only a limited number of EPF-derived metabolites have been experimentally validated as direct tyrosine kinase inhibitors, accumulating evidence indicates that many modulate kinase-associated signalling pathways and represent promising starting points for kinase-oriented natural product discovery. Particular emphasis is placed on pathway activation, heterologous expression, metabolic engineering, and scalable bioprocess development. Key translational challenges, including selectivity, toxicity, yield instability, and regulatory considerations, are also discussed. Collectively, this review highlights EPF as promising microbial platforms for kinase-oriented natural product discovery and provides a biotechnology-focused framework for advancing fungal secondary metabolites toward translational development. Key points • Entomopathogenic fungi encode diverse kinase-active secondary metabolites. • Genome mining and synthetic biology unlock cryptic TKI pathways. • Biotechnological optimization is critical for scalable fungal TKI discovery.

Authors

Institutions

Publication Details

Journal
Applied Microbiology and Biotechnology
Published
2026-08-03
DOI
https://doi.org/10.1007/s00253-026-13975-y
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery

Nkeiruka Grace Osuafor, Daniel Ikechukwu Oraekei, Victor Uchenna Chigozie, Kennedy Izuchukwu Ogunwa et al.
Applied Microbiology and Biotechnology
Microbial Natural Products and Biosynthesis
article

Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery

Nkeiruka Grace Osuafor, Daniel Ikechukwu Oraekei, Victor Uchenna Chigozie, Kennedy Izuchukwu Ogunwa, Leslie Luxe Nduwimana
article en

Abstract

Abstract Tyrosine kinase inhibitors (TKIs) remain a major focus of targeted therapeutic discovery, yet current discovery pipelines are constrained by resistance development, limited scaffold diversity, and high attrition rates. Entomopathogenic fungi (EPF) represent an underexplored microbial resource with significant biosynthetic potential for generating kinase-relevant secondary metabolites. Recent genomic studies reveal that EPF encode diverse and largely cryptic biosynthetic gene clusters (BGCs), including polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS), and hybrid pathways capable of producing structurally complex bioactive compounds. This mini-review examines the biotechnological exploitation of EPF for TKI discovery, focusing on fungal metabolites with direct or indirect kinase-related activity, genome mining strategies, biosynthetic logic, pathway regulation, and engineering approaches for metabolite production. Although only a limited number of EPF-derived metabolites have been experimentally validated as direct tyrosine kinase inhibitors, accumulating evidence indicates that many modulate kinase-associated signalling pathways and represent promising starting points for kinase-oriented natural product discovery. Particular emphasis is placed on pathway activation, heterologous expression, metabolic engineering, and scalable bioprocess development. Key translational challenges, including selectivity, toxicity, yield instability, and regulatory considerations, are also discussed. Collectively, this review highlights EPF as promising microbial platforms for kinase-oriented natural product discovery and provides a biotechnology-focused framework for advancing fungal secondary metabolites toward translational development. Key points • Entomopathogenic fungi encode diverse kinase-active secondary metabolites. • Genome mining and synthetic biology unlock cryptic TKI pathways. • Biotechnological optimization is critical for scalable fungal TKI discovery.

Applied Microbiology and Biotechnology
International Food Policy Research Institute (US), Federal University of Technology (NG), Nnamdi Azikiwe University (NG), Université du Burundi (BI), Federal Ministry of Health (NG), Republic of Burundi (BI), University of Abuja (NG), Ebonyi State University (NG)
Responsible consumption and production
Openalex Percentile: Top 10%
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.